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IN-VITRO GROWTH CHARACTERISTICS OF COMMERCIAL PROBIOTIC STRAINS AND THEIR 
POTENTIAL FOR INHIBITION OF CLOSTRIDIUM DIFFICILE AND CLOSTRIDIDUM PERFRINGENS 
 
Material and Methods 
Seventeen probiotic strains were used (Table 1). 
Inhibition of  C. difficile and C. perfringens 
The effect of a cell free probiotic culture 
supernatant on the growth of C. difficile ribotype 
078 and C. perfringens Type C was assessed.  
Supernatant was harvested and sterilized after 12, 
24, 36, 48, and 72 hours and six days. One aliquot 
was adjusted to pH7.4 (pHadj) the other aliquot was 
left at original pH (pHorig).  
Agar well diffusion assay 
The anti-clostridial activity was evaluated by agar 
well diffusion following addition of supernatant at 
pHorig or pHadj . 
Broth co-culture in Brain Heart Infusion (BHI) 
BHI broth was inoculated with C. difficile or 
C. perfringens and probiotic supernatant (t48h, 
pHorig or pHadj). Clostridial growth was compared to 
growth of a control culture with Man-Rogosa-
Sharpe (MRS) at pH7.0 or pH3.9 instead of 
supernatant using spectophotometry. Inhibition was 
indicated by a reduction of growth of at least 50%. 
Evaluation of growth characteristics 
Aerobic and anaerobic growth of probiotics was 
assessed visually. Growth was compared between 
growth in standard MRS broth, MRS pH2.0 and 
pH4.0, and MRS supplemented with 0.15% and 
0.3% bile spectophotometrically. 
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Results 
Inhibition of  C. difficile and C. perfringens 
Agar well diffusion assay (Fig. 1) 
• 2/17 strains inhibited C. perfringens (Tab. 1) 
o Supernatant from all timepoints (growth phases) 
was inhibitory  
o Supernatant at pHorig and pHadj was inhibitory 
o Inhibition of pHorig was greater indicating presence 
of an additional antibiotic compound other than 
organic acids 
• 10/ 12 strains inhibited C. difficile (Tab. 1) 
o Only supernatant with pHorig was inhibitory 
indicating inhibition due to organic acids 
o Only supernatant harvested after at least 36h of 
incubation inhibited C. difficile. 
Broth co-culture 
• 5/17 probiotics inhibited C. perfringens and 10/17 
inhibited C. difficile  (Tab. 1) 
• Inhibition was only seen with supernatant at pHorig  
Growth characteristics 
• All strains grew aerobically except B. animalis lactis. 
• None of the strains grew at pH2, growth at pH4 
ranged between 40-95% 
• Growth ranged from 40-99%  when bile was added 
• Growth parameters of selected probiotic strains that 
showed inhibitory potential against both clostridia are 
presented in Table 2. 
 
 
Conclusions 
• 5 strains (L. plantarum (n=2),  L. rhamnosus 
(n=2) and B. animalis lactis) inhibit clostridial 
growth by a reduction of pH.  This inhibitory 
effect is likely due to organic acid production 
during stationary growth phase 
• 2 of the 5 strains (L. plantarum, B. animalis) 
produce an additional antibiotic compound 
that inhibits C. perfringens only. This 
compound is produced during the exponential 
phase and it’s activity is pH-independent.   
•These 5 strains show growth characteristics 
suitable for probiotics and their possible use 
for control of clostridial disease will be 
further explored by in-vitro and in-vivo 
studies.   
    
 
 
 
 
 
 
 
F A C U L T Y   O F   H E A L T H   A N D   M E D I C A L   S C I E N C E S 
U N I V E R S I T Y   O F  C O P E N H A G E N 
Background 
C. difficile and C. perfringens are important animal 
pathogens. There are currently no preventative 
measures and therapeutics are limited to 
antibiotics. With antibiotic resistance on the rise 
new approaches are needed. 
Probiotics have been evaluated in humans in 
relation to clostridial disease and results have been 
promising. There are no animal probiotics licensed 
for use against clostridial disease. 
Many strains that show promising activity can not 
be commercially produced as they are not 
technically robust. This could be overcome by 
using strains already in commercial production. 
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Figure 1 Inhibition of C. perfringens by cell-free 
supernatants at pHorig and pHadj , obtained from B. 
animalis lactis BLC1 and unsuccessful inhibition by 
L. plantarum LBd. 
12h, 24h, 36h, 48h: Probiotic supernatant obtained 
after respective incubation time. 
Center well: Sterile MRS broth adjusted to pH3.9 or 
standard MRS broth (pHorig) 
Objective and Hypothesis 
1)To assess the ability of selected commercial 
probiotic strains to inhibit growth of C. difficile 
and/or C. perfringens in vitro  
2)To evaluate their ability to grow in the presence 
of oxygen, acid and bile 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Inhibitory activity of probiotic supernatant against C. perfringens and  
C. difficile in agar well diffusion and broth co-culture assays. Probiotics outlined in 
yellow and blue showed inhibition against both clostridia. Probiotics outlined in blue 
showed inhibition against both clostridia in both assays.  Fields outlined in green show 
inhibitory potential in the respective experiment against the respective clostridial 
strain. 
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Table 2 Growth characteristics of  5 selected probiotic strains with inhibitory activity 
against clostridia in standard Man-Rogosa-Sharp (MRS) broth, MRS broth adjusted to 
pH2.0 and pH4.0, and MRS broth with 0.3% or 0.15% bile added. The numbers are given 
as percentage of growth compared to growth in normal MRS broth 
Trade MRS pH 4 pH 2 Bile Bile
Name 0.3% 0.15%
L. plantarum BG112 100 81 1 85 95
L. rhamnosus LRH19 100 40 0 63 83
L. plantarum LPAL 100 60 1 90 99
L. rhamnosus SP1 100 75 0 71 81
B. animalis spp lactis BLC1 100 77 0 92 96
Strain
Growth in % compared to MRS
Enhedens navn 
12h 
12h 
12h 
12h 24h 
24h 
24h 
24h 
36h 
36h 36h 
36h 
48h 
48h 48h 
48h 
MRS pH 3.9 
MRS pHorig MRS pHorig MRS pH 3.9 
C. perfringens 
pHorig (3.8-4.9)  pHadj 7.4 
C. perfringens 
pHadj 7.4 pHorig (3.8-4.9)  
L. plantarum 
LBd 
B. animalis 
 lactis 
Trade
Name Agar Well Broth Agar Well Broth
L. plantarum BG112 √ √ x √
E. faecium EF1 x x x x
L. casei LC11 √ √ x x
L. rhamnosus LRH19 √ √ x √
L. fermentum Lba x x x x
L. helveticus LH62 x x x x
L. brevis LBR9 x x x x
L. salivarius LBb √ x x x
L. plantarum LBc √ √ x x
L. plantarum LPAL √ √ √ √
L. plantarum LBd √ √ x x
L. casei LC10 x √ x x
L. sakei LS-B x x x x
L. rhamnosus LRB √ √ x x
E. faecium SF02 x x x x
L. rhamnosus SP1 √ √ x √
B. animalis spp lactis BLC1 √ √ √ √
Strain
C. difficile C. perfringens
